DexCom
DXCM
889 hedge funds and large institutions have $24.1B invested in DexCom in 2024 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 332 increasing their positions, 355 reducing their positions, and 198 closing their positions.
5% less call options, than puts
Call options by funds: $404M | Put options by funds: $423M
6% less repeat investments, than reductions
Existing positions increased: 332 | Existing positions reduced: 355
4.61% less ownership
Funds ownership: 94.13% → 89.51% (-4.6%)
11% less funds holding
Funds holding: 999 → 889 (-110)
40% less funds holding in top 10
Funds holding in top 10: 15 → 9 (-6)
43% less capital invested
Capital invested by funds: $42.4B → $24.1B (-$18.4B)
51% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 198
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$537M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$493M |
| 3 |
D.E. Shaw & Co
New York
|
+$197M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$135M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$526M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$513M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$326M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$183M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$151M |
DXCM Hedge Fund Activity: Q3 2024 in Review
889 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2024, worth a combined $24.1B — down 43% from $42.4B a quarter earlier.
Sellers outnumbered buyers: 198 funds closed out of DXCM and 97 opened new positions — a net loss of 101 holders — while 355 trimmed existing stakes and 332 added.
The largest buyer was Jennison Associates, adding an estimated $537M. The largest seller was Fidelity Investments, cutting an estimated $526M.
- 889 institutional investors held DexCom (DXCM) as of Q3 2024, down from 999 in Q2 2024.
- Funds reported $24.1B of DexCom stock for Q3 2024, down 43% quarter-over-quarter.
- 97 funds opened new DexCom positions in Q3 2024 and 198 closed out, a net change of -101 holders.
- The largest DexCom buyer in Q3 2024 was Jennison Associates, an estimated $537M added.
- The largest DexCom seller in Q3 2024 was Fidelity Investments, an estimated $526M sold.
Based on aggregated 13F filings for Q3 2024.